Dnature Bio Labs is striving to grow into an advanced biotech
R&D company that contributes to humanity and society through its
brain healthcare business. We are developing leading bio-pharmaceuticals
for neurodegenerative diseases as well as functional food and beverage
that help improve neural health.
Platform Fetal Neural Stem Cells <DNB100>
We investigate and develop neural cell therapies forVIEW MORE
Amyotrophic Lateral Sclerosis (Lou Gehrig's disease),
Stroke, and Alzheimer's disease via isolation &
cultivation of fetal neural stem/progenitor cells.
Pipeline Lou Gehrig's Disease
Cell Therapy <DNB120>
As a therapy for Amypotrophic Lateral SclerosisVIEW MORE
(Lou Gehrig's disease), neural cell therapy is being
developed under the R&D strategies such as glial cell
therapy, neuroprotection, neuroregeneration, allogeneic
cell therapy, off-the shelf, and orphan drug.
Pipeline Stroke Cell Therapy <DNB130>
As a therapy for Stroke, neural cell therapy isVIEW MORE
being developed under R&D strategies such as neural
cell therapy, neuroprotection, neuroregeneration,
allogeneic cell therapy, off-the shelf, and expansion
into another indication.